Variant (isolate detected, n) | Fisher’s exact test | ROC curve | |||||
---|---|---|---|---|---|---|---|
Susceptible | Non-susceptible | P-value | AUROC (SE) | Sensitivity | Specificity | P-value | |
Cefuroxime | 18 | 8 | Â | Â | Â | Â | Â |
 HI_1132 (ftsI) | |||||||
  1070G > A (Ser357Asn) | 6 | 7 | 0.030 | 0.805 (0.087) | 76.9% | 69.2% | 0.008 |
  1594A > T (Thr532Ser) | 1 | 4 | 0.020 | 0.910 (0.066) | 80.0% | 85.7% | 0.005 |
  1669 T > C (Tyr557His) | 1 | 5 | 0.004 | 0.946 (0.050) | 83.3% | 90.0% | 0.001 |
 HI_1655 (lpoA) | |||||||
  453G > C (Met151Ile) | 0 | 3 | 0.022 | 0.891 (0.071) | 100.0% | 82.6% | 0.030 |
Amoxicillin-clavulanate | 22 | 4 | Â | Â | Â | Â | Â |
 HI_0032 (mrdA) | |||||||
  1552G > A (Ala518Thr) | 6 | 4 | 0.014 | 0.750 (0.101) | 50.0% | 100.0% | 0.035 |
 HI_0197 (mepA) | |||||||
  82C > A (Gln28Lys) | 4 | 3 | 0.047 | 0.767 (0.125) | 57.1% | 94.7% | 0.040 |
 HI_0364 (pbpG) | |||||||
  674G > T (Arg225Leu) | 6 | 4 | 0.014 | 0.859 (0.073) | 70.0% | 81.2% | 0.002 |
Ciprofloxacin / Levofloxacin | 11 | 15 | Â | Â | Â | Â | Â |
 HI_1264 (gyrA) | |||||||
  251C > T (Ser84Phe) | 4 | 13 | 0.014 | 0.752 (0.103) | 86.7% | 63.6% | 0.031 |
  263A > G (Asp88Gly) | 0 | 7 | 0.010 | 0.733 (0.098) | 46.7% | 100.0% | 0.046 |
  1299G > T (Glu433Asp) | 1 | 9 | 0.014 | 0.755 (0.097) | 60.0% | 90.9% | 0.029 |
  1414A > G (Ile472Val) | 1 | 10 | 0.005 | 0.788 (0.092) | 66.7% | 90.9% | 0.014 |
  2220 T > A (Asp740Glu) | 1 | 8 | 0.036 | 0.721 (0.101) | 53.3% | 90.9% | 0.058 |
 HI_0567 (gyrB) | |||||||
  1817C > T (Ala606Val) | 5 | 13 | 0.038 | 0.706 (0.109) | 86.7% | 54.5% | 0.078 |
  2174C > T (Ala725Val) | 1 | 9 | 0.014 | 0.755 (0.097) | 60.0% | 90.9% | 0.029 |
 HI_1529 (parC) | |||||||
  59A > G (Lys20Arg) | 0 | 11 |  < 0.001 | 0.867 (0.074) | 73.3% | 100.0% | 0.002 |
  251G > T (Ser84Ile) | 1 | 11 | 0.002 | 0.821 (0.087) | 73.3% | 90.9% | 0.006 |
  1601G > A (Ser534Asn) | 0 | 6 | 0.024 | 0.700 (0.102) | 40.0% | 100.0% | 0.087 |
 HI_1528 (parE) | |||||||
  434G > A (Ser145Asn) | 0 | 8 | 0.007 | 0.767 (0.094) | 53.3% | 100.0% | 0.022 |
 parC-parE intergenic region | |||||||
  n.1600250A > C | 0 | 11 |  < 0.001 | 0.867 (0.074) | 73.3% | 100.0% | 0.002 |
Trimethoprim-sulfamethoxazole | 6 | 20 | Â | Â | Â | Â | Â |
 HI_0899 (folA) | |||||||
  38A > G (Asn13Ser) | 1 | 19 |  < 0.001 | 0.954 (0.047) | 100.0% | 83.3% |  < 0.001 |
  63G > A (Met21Ile) | 0 | 11 | 0.024 | 0.585 (0.114) | 100.0% | 40.0% | 0.467 |
  200T > C (Leu67Pro) | 0 | 13 | 0.015 | 0.654 (0.112) | 100.0% | 46.2% | 0.182 |
  250A > T (Asn84Tyr) | 0 | 11 | 0.024 | 0.585 (0.114) | 100.0% | 40.0% | 0.467 |
  283A > C (Ile95Leu) | 1 | 17 | 0.004 | 0.795 (0.112) | 100.0% | 62.5% | 0.018 |
  319A > C (Lys107Gln) | 0 | 16 |  < 0.001 | 0.775 (0.106) | 100.0% | 60.0% | 0.020 |